Literature DB >> 25703588

Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis.

L Benetatos1, G Vartholomatos2.   

Abstract

Genomic imprinting is characterized by the parent-of-origin monoallelic expression of several diploid genes because of epigenetic regulation. Imprinted genes (IGs) are key factors in development, supporting the ability of a genotype to produce phenotypes in response to environmental stimuli. IGs are highly expressed during prenatal stages but are downregulated after birth. They also affect aspects of life other than growth such as cognition, behavior, adaption to novel environments, social dominance and memory consolidation. Deregulated genomic imprinting leads to developmental disorders and is associated with solid and blood cancer as well. Several data have been published highlighting the involvement of IGs in as early as the very small embryonic-like stem cells stage and further during myeloid lineage commitment in normal and malignant hematopoiesis. Therefore, we have assembled the current knowledge on the topic, based mainly on recent findings, trying not to focus on a particular cluster but rather to have a global view of several different IGs in hematopoiesis.

Entities:  

Mesh:

Year:  2015        PMID: 25703588     DOI: 10.1038/leu.2015.47

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  140 in total

1.  Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

Authors:  Bjarki Johannesson; Ido Sagi; Athurva Gore; Daniel Paull; Mitsutoshi Yamada; Tamar Golan-Lev; Zhe Li; Charles LeDuc; Yufeng Shen; Samantha Stern; Nanfang Xu; Hong Ma; Eunju Kang; Shoukhrat Mitalipov; Mark V Sauer; Kun Zhang; Nissim Benvenisty; Dieter Egli
Journal:  Cell Stem Cell       Date:  2014-11-06       Impact factor: 24.633

Review 2.  X-inactivation, imprinting, and long noncoding RNAs in health and disease.

Authors:  Jeannie T Lee; Marisa S Bartolomei
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

3.  Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains.

Authors:  Jennifer J Trowbridge; Amit U Sinha; Nan Zhu; Mingjie Li; Scott A Armstrong; Stuart H Orkin
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

Review 4.  The evolution of genomic imprinting: theories, predictions and empirical tests.

Authors:  M M Patten; L Ross; J P Curley; D C Queller; R Bonduriansky; J B Wolf
Journal:  Heredity (Edinb)       Date:  2014-04-23       Impact factor: 3.821

5.  Evaluation of allelic expression of imprinted genes in adult human blood.

Authors:  Jennifer M Frost; Dave Monk; Taita Stojilkovic-Mikic; Kathryn Woodfine; Lyn S Chitty; Adele Murrell; Philip Stanier; Gudrun E Moore
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

6.  Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group.

Authors:  Verena Ingeborg Gaidzik; Richard Friedrich Schlenk; Simone Moschny; Annegret Becker; Lars Bullinger; Andrea Corbacioglu; Jürgen Krauter; Brigitte Schlegelberger; Arnold Ganser; Hartmut Döhner; Konstanze Döhner
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

Review 7.  Dosage-sensitivity of imprinted genes expressed in the brain: 15q11-q13 and neuropsychiatric illness.

Authors:  Gráinne I McNamara; Anthony R Isles
Journal:  Biochem Soc Trans       Date:  2013-06       Impact factor: 5.407

Review 8.  The role of genomic imprinting in biology and disease: an expanding view.

Authors:  Jo Peters
Journal:  Nat Rev Genet       Date:  2014-06-24       Impact factor: 53.242

9.  Leukemia cells induce changes in human bone marrow stromal cells.

Authors:  Sara Civini; Ping Jin; Jiaqiang Ren; Marianna Sabatino; Luciano Castiello; Jianjian Jin; Huan Wang; Yuanlong Zhao; Francesco Marincola; David Stroncek
Journal:  J Transl Med       Date:  2013-12-04       Impact factor: 5.531

10.  Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells.

Authors:  D M Shin; E K Zuba-Surma; W Wu; J Ratajczak; M Wysoczynski; M Z Ratajczak; M Kucia
Journal:  Leukemia       Date:  2009-07-30       Impact factor: 11.528

View more
  4 in total

1.  Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor.

Authors:  Fiona Poyer; Raúl Jimenez Heredia; Wolfgang Novak; Petra Zeitlhofer; Karin Nebral; Michael N Dworzak; Oskar A Haas; Kaan Boztug; Leo Kager
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

2.  Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.

Authors:  Zachariah Payne Sellers; Lukasz Bolkun; Janusz Kloczko; Marzena Liliana Wojtaszewska; Krzysztof Lewandowski; Marcin Moniuszko; Mariusz Z Ratajczak; Gabriela Schneider
Journal:  Clin Epigenetics       Date:  2019-03-15       Impact factor: 6.551

3.  Assisted Reproductive Technology and Risk of Childhood Cancers.

Authors:  Shiue-Shan Weng; Yen-Tsung Huang; Yi-Ting Huang; Yi-Ping Li; Li-Yin Chien
Journal:  JAMA Netw Open       Date:  2022-08-01

4.  Novel evidence that pituitary gonadotropins directly stimulate human leukemic cells-studies of myeloid cell lines and primary patient AML and CML cells.

Authors:  Ahmed Abdelbaset-Ismail; Sylwia Borkowska; Anna Janowska-Wieczorek; Torsten Tonn; Cesar Rodriguez; Marcin Moniuszko; Lukasz Bolkun; Janusz Koloczko; Andrzej Eljaszewicz; Janina Ratajczak; Mariusz Z Ratajczak; Magda Kucia
Journal:  Oncotarget       Date:  2016-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.